Last updated: 18 June 2019 at 5:15am EST

Kevin T. Gray Net Worth




The estimated Net Worth of R Paul Gray is at least $2.6 Million dollars as of 1 November 2013. Kevin Gray owns over 7,500 units of United Therapeutics Corp stock worth over $2,596,425 and over the last 20 years he sold UTHR stock worth over $0.

Kevin Gray UTHR stock SEC Form 4 insiders trading

Kevin has made over 33 trades of the United Therapeutics Corp stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of UTHR stock worth $360,825 on 1 November 2013.

The largest trade he's ever made was exercising 66,000 units of United Therapeutics Corp stock on 3 May 2011 worth over $2,346,960. On average, Kevin trades about 3,978 units every 67 days since 2005. As of 1 November 2013 he still owns at least 7,500 units of United Therapeutics Corp stock.

You can see the complete history of Kevin Gray stock trades at the bottom of the page.





Kevin T. Gray biography

Kevin T. Gray is the Sr. VP of Strategic Operations & Logistics at United Therapeutics Corp.



What's Kevin Gray's mailing address?

R's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORP, 1110 SPRING STREET, SILVER SPRINGS, MD, 20910.

Insiders trading at United Therapeutics Corp

Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli, and Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.



What does United Therapeutics Corp do?

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians



Complete history of Kevin Gray stock trades at United Therapeutics Corp

Insider
Trans.
Transaction
 Total value
R Paul Gray
Director
 Option $360,825
1 Nov 2013
R Paul Gray
Director
 Option $360,825
31 Jul 2013
R Paul Gray
Director
 Option $2,346,960
3 May 2011
R Paul Gray
Director
 Option $61,500
2 May 2011
R Paul Gray
Director
 Option $61,500
1 Apr 2011
R Paul Gray
Director
 Option $61,500
1 Mar 2011
R Paul Gray
Director
 Option $61,500
1 Feb 2011
R Paul Gray
Director
 Option $62,340
3 Jan 2011
R Paul Gray
Director
 Option $62,340
1 Dec 2010
R Paul Gray
Director
 Option $124,680
3 Nov 2010
R Paul Gray
Director
 Option $62,340
7 Oct 2010
R Paul Gray
Director
 Option $49,860
10 Sep 2010
R Paul Gray
Director
 Option $5,540
3 Sep 2010
R Paul Gray
Director
 Option $55,400
5 Aug 2010
R Paul Gray
Director
 Option $55,400
9 Jul 2010
R Paul Gray
Director
 Option $55,400
3 Jun 2010
R Paul Gray
Director
 Option $166,200
6 May 2010
R Paul Gray
Director
 Option $166,200
1 Apr 2010
R Paul Gray
Director
 Option $166,200
4 Mar 2010
R Paul Gray
Director
 Option $110,800
11 Feb 2010
R Paul Gray
Director
 Option $48,780
11 Feb 2010
R Paul Gray
Director
 Option $159,600
7 Jan 2010
R Paul Gray
Director
 Option $146,340
16 Dec 2009
R Paul Gray
Director
 Option $187,020
6 Aug 2009
R Paul Gray
Director
 Option $146,340
5 Aug 2008
R Paul Gray
Director
 Option $361,920
6 May 2008
R Paul Gray
Director
 Option $101,120
6 Nov 2007
R Paul Gray
Director
 Option $75,840
3 Aug 2007
R Paul Gray
Director
 Option $126,400
3 Nov 2006
R Paul Gray
Director
 Option $116,350
7 Aug 2006
R Paul Gray
Director
 Option $46,540
3 Nov 2005
R Paul Gray
Director
 Option $46,540
15 Aug 2005
R Paul Gray
Director
 Option $76,950
6 May 2005


United Therapeutics Corp executives and stock owners

United Therapeutics Corp executives and other stock owners filed with the SEC include: